[{"id":"099b5bf4-7bd1-4b6b-9199-1c53110e04ad","acronym":"DALY 2-EU","url":"https://clinicaltrials.gov/study/NCT04844866","created_at":"2021-04-14T11:52:59.944Z","updated_at":"2024-07-02T16:35:06.971Z","phase":"Phase 2","brief_title":"Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients","source_id_and_acronym":"NCT04844866 - DALY 2-EU","lead_sponsor":"Miltenyi Biomedicine GmbH","biomarkers":" BCL2 • CD19 • BCL6","pipe":" | ","alterations":" CD19 expression • BCL6 rearrangement • BCL2 rearrangement","tags":["BCL2 • CD19 • BCL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression • BCL6 rearrangement • BCL2 rearrangement"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e gemcitabine • Rituxan (rituximab) • oxaliplatin • bendamustine • Polivy (polatuzumab vedotin-piiq) • zamtocabtagene autoleucel (MB-CART2019.1)"],"overall_status":"Recruiting","enrollment":" Enrollment 168","initiation":"Initiation: 08/18/2021","start_date":" 08/18/2021","primary_txt":" Primary completion: 12/31/2024","primary_completion_date":" 12/31/2024","study_txt":" Completion: 07/31/2027","study_completion_date":" 07/31/2027","last_update_posted":"2024-04-30"},{"id":"8dda46df-1947-4289-9d30-b835dca6e2d3","acronym":"","url":"https://clinicaltrials.gov/study/NCT03870945","created_at":"2021-01-18T19:05:14.371Z","updated_at":"2024-07-02T16:35:06.813Z","phase":"Phase 1/2","brief_title":"Safety of MB-CART2019.1 in Lymphoma Patients (MB-CART2019.1 Lymphoma / DALY 1)","source_id_and_acronym":"NCT03870945","lead_sponsor":"Miltenyi Biomedicine GmbH","biomarkers":" BCL2 • BCL6","pipe":" | ","alterations":" CD19 expression • BCL6 rearrangement • BCL2 rearrangement","tags":["BCL2 • BCL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression • BCL6 rearrangement • BCL2 rearrangement"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e zamtocabtagene autoleucel (MB-CART2019.1)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 02/25/2019","start_date":" 02/25/2019","primary_txt":" Primary completion: 12/17/2020","primary_completion_date":" 12/17/2020","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2024-04-30"}]